Apri index. APRI (AST to Platelet Ratio Index) is used to assess liver fibrosis severity in individuals with liver-related conditions, such as viral hepatitis or alcoholic liver disease. Understanding the APRI Score The APRI score is primarily used to assess the likelihood of liver fibrosis, which is the scarring of liver About APRI Calculator The AST to Platelet Ratio Index (APRI) is a validated non-invasive tool used to assess liver fibrosis risk in patients with chronic liver disease, particularly in viral hepatitis. PPV: positive predictive value. 0 had a sensitivity of 76% and specificity of 72% for predicting cirrhosis. 5 for Oct 18, 2023 · AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects Article Open access 21 July 2021 Aug 21, 2019 · The indexes including AST-to-platelet ratio index (APRI), γ-GT and lactate dehydrogenase (LDH) were independent risk factors for SALI. APRI, or AST to Platelet Ratio Index, is your new best friend in determining the level of fibrosis in your liver. AST (Aspartat-Aminotransferase) = GOT (Glutamat-Oxalacetat-Transaminase) Bei einem errechneten Wert von > 1,5 ist eine Fibrose sehr wahrscheinlich, bei Werten < 0,5 gilt eine Fibrose als praktisch ausgeschlossen. Jul 21, 2021 · The AST to Platelet Ratio Index (APRI score) is an easy-to-use score to predict liver fibrosis 18, such as other noninvasive serum markers (FIB-4 index, FLI, NFS, BARD, Forns index 19). 5 for fibrosis and 1. Calculate the AST to Platelet Ratio Index (APRI) with this APRI Calculator. Enter the required values to calculate the APRI value. APRI score measures the amount of fibrosis in the liver. Mar 16, 2024 · Prior to the development of widely used noninvasive tests that estimate hepatic fibrosis, such as aspartate aminotransferase-to-platelet ratio index (APRI), FibroSure, FibroTest, and transient elastography (FibroScan), liver biopsy was used to estimate liver fibrosis. Aspartate aminotransferase to platelet ratio index (APRI), a newer prognostic modality, is a very Enjoy free text messaging and MMS on your computer or smart phone. Calculate AST to Platelet Ratio Index (APRI), a non-invasive marker for liver fibrosis and cirrhosis. Healthcare providers use the APRI score when they suspect liver fibrosis or cirrhosis and want to assess the extent of fibrosis without the need for a liver biopsy. CI, 95%: Confidence Interval. スコアリングシステムとは、主に血液などの生化学検査データを組み合わせて、精度を高めて評価するための手法です。血液検査は肝臓以外の要素や目的外の要素が影響する可能性があるため、複数の項目を組み合わせたスコアリングシステムを用いることで、それらの可能性を少なくしてい We would like to show you a description here but the site won’t allow us. El estándar es la clasificación histológica mediante la escala de Metavir, ya que frecuentemente no es posible llevar a cabo la biopsia de hígado. Data of 530 consecutive patients undergoing robotic hepatectomy were analyzed. Mar 25, 2025 · APRI Score Calculation Example: The APRI (AST to Platelet Ratio Index) score is a non-invasive marker used to assess the degree of liver fibrosis. Apr 1, 2025 · Aspartate aminotransferase-to-platelet ratio index (APRi), a non-invasive biomarker, shows promise in assessing fibrosis and cirrhosis severity, offering an alternative to liver biopsy. Für das Vorliegen einer Dec 1, 2023 · APRi (AST-to-platelet ratio index) is a simple surrogate marker of liver fibrosis and we sought to determine its long-term relationship (if any) with outcome post-Kasai portoenterostomy (KPE). www. 5 indicates significant hepatic fibrosis. Future studies of novel markers should demonstrate improved accuracy and cost-effectiveness compared with this economical and widely available index. Moreover, APRI was powerful to predict SALI in children (AUC: 0. Material and methods: In a cohort of patients with ALD, the value of the APRI index and liver biopsy results were determined according to the METAVIR score. Keywords: aspartate aminotransferase-to-platelet ratio index (apri score), liver fibrosis indices, fatty liver, metabolic syndrome, diabetes mellitus Jan 24, 2023 · Given fibrosis has shown to correlate with malignancy and the aminotransferase-platelet ratio index (APRI) score, a marker for hepatic fibrosis, has shown to be useful in prognosticating hepatocellular carcinoma, this study aimed to assess the utility of APRI score in prognosticating post-surgical outcomes in CCA patients. Jan 26, 2016 · 这例患者的APRI评分>2，说明他可能已经发展到肝硬化阶段。 研究显示，这种方法诊断肝硬化的准确性在80%左右。 美国的丙型肝炎在线网站把APRI评分的公式程序直接放到了网上。 The APRI score may not be the perfect differentiating method for the severity of ICP but it may help the clinician working with limited resources. The aspartate aminotransferase to platelet ratio index (APRI) has been proposed as a noninvasive and readily available tool for the assessment of liver fibrosis in chronic hepatitis C (CHC). NPV: negative predictive value. In light of the uncertain clinical utility of APRI and FIB-4 in patients with CHB infection, we systematically reviewed the diagnostic accuracy of APRI and FIB-4 for the prediction of HBV-related fibrosis. APRI and ELF ™ tests are able to differentiate mild and significant fibrosis The results of the APRI and the ELF™ tests for the training and validation patient sets are summarized in Tables 2 and 3. pathway. The objective of the present study was to evaluate the clinical and predictive value of APRI in a paediatric obese population. The aspartate aminotransferase to platelet ratio index (APRI) has been propos… APRi (AST-to-platelet ratio index) is a simple surrogate marker of liver fibrosis and we sought to determine its long-term relationship (if any) with outcome post-Kasai portoenterostomy (KPE). Abstract Liver biopsy is the recognized gold standard for liver fibrosis staging. A subgroup analyses was carried out, evaluating only patients who had hepatitis C related cirrhosis (72 cases, after excluding patients who had association of hepatitis C and alcohol abuse). Calculating a patient's APRI score allows clinicians to easily predict hepatic fibrosis without performing a more invasive medical tests, e. For prediction of AF in NAFLD, m-APRI outperforms BARD, APRI, NFS and FIB-4, while for the prediction of cirrhosis, m-APRI is superior to APRI and BARD but comparable to NFS and FIB-4. Aug 18, 2014 · The results regarding which index performs better for the diagnosis of liver fibrosis in HBV-related patients are inconsistent. Feb 26, 2025 · The aspartate aminotransferase-to-platelet ratio index (APRI) is a non-invasive index widely used to assess liver fibrosis and prognosis, and it has been shown to have a high diagnostic value in predicting the degree of liver fibrosis [8]. It is calculated using the formula APRI = (AST / ULN) / PLT * 100, where AST is the Aspartate Aminotransferase level, ULN is the Upper Limit of Normal AST, and PLT is the platelet count. Nov 13, 2018 · The aspartate aminotransferase-to-platelet-ratio index (APRI), a noninvasive surrogate for liver fibrosis, utilizes routinely obtained serum markers and is especially useful when alternative noninvasive options are unavailable [2]. It helps evaluate the likelihood of liver fibrosis or cirrhosis by utilizing common blood test results to indicate liver scarring. The predictive accuracy of APRI for significant fibrosis and cirrhosis was tested by the areas under the receiver operating characteristic curves (AUROC). Patients were classified based on an APRI score threshold of 0. Oct 1, 2024 · The APRI score helps detect liver fibrosis for people with liver disease. Liver biopsy is the recognized gold standard for liver fibrosis staging. Studies validating APRI have primarily been cross-sectional [3–5]. APRI: aspartate aminotransferase-to-platelet ratio index. El índice APRI es un modelo bioquímico no invasivo a partir de niveles de plaquetas y aspartato amino transferasa (AST) para la predicción de fibrosis hepática. Feb 26, 2025 · The prediction value of APRI for 2-year NLS time increases when combined with other indicators, and is better than single indicator, the prediction value is strongest when APRI is combined with all indicators. ¿Para qué sirve el APRI? APRI and Fib-4 scores are reasonable tools to allocate NAFLD patients with advanced fibrosis. Free AST-to-platelet ratio calculator with fibrosis and cirrhosis cutoffs. Jul 9, 2022 · Objective: To assess the AST-to-Platelet Count Index (APRI) as a means to predict the advance of cirrhosis stages as indicated in Child-Pugh classification. Oct 1, 2024 · What Is the APRI Score? APRI is short for aspartate aminotransferase to platelet ratio index. APRI has been used for predicting liver-related mortality in patients with chronic hepatitis C virus infection o … May 18, 2022 · Abstract Background: Aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) are the two most widely studied noninvasive markers of liver fibrosis. Assess likelihood of fibrosis or cirrhosis non-invasively using AST and platelet count. Calculate the AST to Platelet Ratio Index (APRI) to estimate liver fibrosis and cirrhosis in hepatitis C patients. Calculator: Aspartate aminotransferase (AST) to platelet ratio index (APRI) in adults (conventional units)* To continue reading this article, you must sign in with your personal, hospital, or group practice subscription. The APRI (ASAT-to-platelet ratio index) test was calculated according to the standard formula. AST to Platelet Ratio Index (APRI) is a blood-based liver test based on the amount of aspartate aminotransferase (AST) and platelets in a person’s body. Free online tool for medical professionals. Jul 6, 2025 · The APRI (AST to Platelet Ratio Index) is a simple, non-invasive scoring system used to estimate the degree of liver fibrosis in patients with chronic liver disease, most notably chronic hepatitis C. We found APRI to be the best index to predict advanced liver fibrosis compared to FIB-4 and AST/ALT ratio, with this index having the strongest correlation with FibroScan results. Learn the interpretation, sensitivity, specificity and sources of the APRI score. FS is a reliable predictor of significant fibrosis and cirrhosis in Western Chinese patients with chronic HBV infection, and is superior to APRI and FIB-4. md Aug 2, 2025 · The Aspartate Aminotransferase to Platelet Ratio Index, or APRI score, is a non-invasive method for assessing liver health. Enter laboratory data to calculate the APRI score and evaluate liver health. 889, 95% CI: 0. Always stay in touch! Mar 4, 2026 · Leber: AST/Thrombozyten-Ratio-Index (APRI) Die invasive Leberbiopsie ist der Gold-Standard, um vor einer Therapie die Diagnose und Stadieneinteilung der Leberfibrose vorzunehmen. AST to Platelet Ratio Index (APRI) Calculator Share This is an A ST to P latelet R atio I ndex (APRI) calculator tool. The major strength of the APRI is the exclusion of significant HCV-related fibrosis. AST to Platelet Ratio Index (APRI) Calculator This is an A ST to P latelet R atio I ndex (APRI) calculator tool. FIB-4 may better discriminate between intermediate fibrosis stages. Jul 21, 2021 · The APRI index is obtained from AST and platelet counts, and it is also used to assess liver fibrosis associated with hepatitis B or C (51), with a cut-off point of 0. 3 % at the cutoff point of 0. Use the APRI calculator to assess the risk of liver fibrosis. Usefulness of this marker seems to depend on the etiology of liver damage. Thus, in this cross-sectional study, we investigated in a population of 1225 subjects if AST to Platelet Ratio Index (APRI), one of the non-invasive liver fibrosis serum markers, can predict cardiovascular risk (CVR). Platelet count is an integral part of AST to platelet ratio index (APRI), fibrosis score of 4 (FIB-4), Fibro-index, Fibrometer and Forns which is often used to predict advanced fibrosis, presence and severity of portal hypertension in predicting oesophageal varices. Copyright 2014-2026 Synnovis Group LLP. May 12, 2025 · Predictive capability of aspartate transaminase-to-platelet ratio index (APRI) in assessing liver fibrosis/cirrhosis. The APRI Calculator or AST to Platelet Ratio Index Calculator is a powerful tool designed to help medical professionals assess liver fibrosis in patients with chronic hepatitis C. Schwere Komplikationen nach Leberbiopsien kommen in 0,3 % vor (3 von 1. However, standardised criteria and research on APRi accuracy in paediatric BA, especially across diverse populations, remain limited. The APRI calculator computes the AST to Platelet Ratio Index (APRI), which we use to predict fibrosis and cirrhosis. Initially validated for patients with chronic hepatitis C (CHC), the APRI is now widely used to evaluate other liver diseases. 天门冬氨酸氨基转移酶与血小板比值（APRI）评分的医学计算工具，用于评估肝纤维化及相关疾病的诊断和治疗。 Nov 25, 2019 · Acute infection with Plasmodium vivax, classically associated with benign disease, has been presenting as serious and even fatal disease in recent years. APRI (aspartate aminotransferase [AST]-to-platelet ratio index) is recommended as the preferred non-invasive test (NIT) to assess for the presence of cirrhosis (APRI score >2 in adults) in resource-limited settings. Essential for assessing liver fibrosis and cirrhosis in patients with hepatitis C. 000), tödliche in 0,03 %. We aimed to assess the diagnostic accuracy of APRI and FIB-4 for liver fibrosis in patients with autoimmune hepatitis (AIH) using liver biopsy as the reference standard. This study aimed to validate, in a M … APRI and FIB-4 Talk to your doctor about using non-invasive calculations such as AST to Platelet Ratio Index (APRI) and Fibrosis-4 index for Liver Fibrosis (FIB-4) to determine if there is evidence of liver disease. Send and receive. AST to Platelet Ratio Index (APRI) is reported to be a simple, noninvasive and readily available laboratory test index that can stratify patients with HCV and nonalcoholic steatohepatitis (NASH), now known as metabolic dysfunction-associated steatohepatitis (MASH), who are at high or low risk for significant fibrosis and cirrhosis with high degree of accuracy. May 15, 2024 · In our study, we aimed to observe the role of a novel indicator, the APRI (Aspartate aminotransferase-to-Platelet ratio index) score, in predicting disease progression since literature analyzing its prognostic value in anticipating dengue severity is scarce. The aspartate transaminase to platelet ratio index (APRI) has been proposed as an easy-to-use biochemical marker in obese adults with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH). It’s a non-invasive method that uses readily available lab test results. However, the prognostic value of APRI in patients with chronic hepatitis with regard . In the present cross-sectional study, the aspartate aminotransferase-to-platelet ratio index (APRI) was evaluated as a method for Apr 19, 2021 · APRI index (Table 1, 2 and 3) uses aspartate transaminase (AST) and platelet count to es timate liver fibrosis, w hich is an extension of liver damage and Nov 1, 2015 · The Aspartate Aminotransferase Platelet Ratio Index (APRI) score is a simple non-invasive diagnostic tool for predicting liver fibrosis and cirrhosis. , biopsy. APRI is a simple and cheap method to ascertain the ratio between AST and platelets and is easy to use in clinical practice. We would like to show you a description here but the site won’t allow us. It offers a non-invasive way to predict which patients have cirrhosis without imaging or biopsy. 7 and extent Background Of liver-related disorders, cirrhosis is currently the leading cause of death and has become a significant global public health concern. Jul 21, 2021 · NAFLD is often linked to metabolic and cardiovascular risk. May 5, 2024 · The APRI index includes two simple and cheap laboratory tests performed routinely in clinical practice. This study aims to evaluate the correlation between APRI scores and perioperative outcomes following robotic hepatectomy. Calculate APRI score for noninvasive liver fibrosis assessment. In this area, of great contemporary interest is the article by Yilmaz et al. The AST to platelet ratio index is a non invasive method that can offer information about risk of hepatic fibrosis and cirrhosis, based on platelet count and aspartate aminotransferase level. g. APRI Calculator The APRI Calculator is a non-invasive alternative to liver biopsy, designed to assess hepatic fibrosis and cirrhosis. Aspartate aminotransferase to platelet ratio index (APRI), a newer prognostic modality, is a very AST-to-Platelet Ratio Index (APRI) APRI ist ein nichtinvasiver Indikator für die Wahrscheinlichkeit einer Leberfibrose im Verlauf einer chronischen HCV-Infektion. This AST to Platelet Ratio Index APRI calculator computes the APRI score based on the platelet count and AST value to check for cirrhosis signs. Oct 1, 2008 · Liver biopsy is the recognized gold standard for liver fibrosis staging. Unlike liver biopsies, this method avoids Aktuelle Seite: Startseite » Rechner » Berechnung: AST-Thrombozyten Ratio-Index (APRI) Drucken E-Mail Die invasive Leberbiopsie ist derzeit der Goldstandard zur Diagnose und Beurteilung des Stadiums einer Leberfibrose. You can read more about the formula used and the accuracy of the test below the form. In a meta-analysis by Lin et al, it was found that in patients with hepatitis C, an APRI score greater than 1. Der AST/Thrombozyten-Ratio-Index (APRI) ist ein nicht-invasiver Marker zur Entdeckung einer Leberfibrose vor allem bei chronischer Hepatitis B und C. The APRI Score will appear in the oval on the far right (highlighted in yellow). An APRI test score higher than 1. Severe disease is mainly due to biochemical and hematological alterations during the acute phase of infection. METAVIR scoring from 14 liver biopsies was compared to the liver stiffness using the Kappa statistic. Find out more about what it is, how it’s calculated, and why doctors use it instead of biopsies. It’s a way for doctors to measure how healthy your liver is when you have a liver disease. AST to Platelet Ratio Index - How to calculate APRI score? The aspartate aminotransferase (AST) to platelet ratio index is an easy, non-invasive alternative to liver biopsy for identifying hepatic fibrosis. Aspartate aminotransferase to platelet ratio index (APRI) has originally been considered as a noninvasive marker for detecting hepatic fibrosis in patients with chronic hepatitis B and C. The aim of this study was to determine diagnostic performance and degree of concordance between the APRI index and liver biopsy for diagnosing cirrhosis in these patients. 927) with a sensitivity of 84. Transient elastography (e. on the usefulness of the aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with CLD [5]. 340. 4 Hence, this score can be used to compare Nov 13, 2019 · Aspartate aminotransferase-to-platelet ratio index (APRI) is widely used in the assessment of fibrosis and cirrhosis, especially in patients with chronic hepatitis. It provides an AST to Platelet Ratio Index (APRI) score using routine blood test parameters. Jan 26, 2016 · 这例患者的APRI评分>2，说明他可能已经发展到肝硬化阶段。 研究显示，这种方法诊断肝硬化的准确性在80%左右。 美国的丙型肝炎在线网站把APRI评分的公式程序直接放到了网上。 Jun 28, 2024 · Conclusion: This research highlights the effectiveness of the APRI index as a reliable predictor of MetS development in individuals with T2DM. AST-to-Platelet Ratio Index (APRI) APRI ist ein nichtinvasiver Indikator für die Wahrscheinlichkeit einer Leberfibrose im Verlauf einer chronischen HCV-Infektion. 851-0. FS cutoff values could be considered as clinical reference for detecting significant fibrosis and cirrhosis. The AST to Platelet Ratio Index (APRI) tool has been found to useful as a non-invasive index that correlates with liver biopsy findings of fibrosis and cirrhosis. Background Of liver-related disorders, cirrhosis is currently the leading cause of death and has become a significant global public health concern. FibroScan) or FibroTest may be the preferred NITs in settings where they are available and cost is not a major constraint. Synnovis, the Synnovis logo and Nutris are registered trademarks of Synnovis Group LLP. The AST to Platelet Ratio Index (APRI) predicts fibrosis and cirrhosis in hepatitis C patients. APRI and Fib-4 scores are reasonable tools to allocate NAFLD patients with advanced fibrosis. The AST to Platelet Ratio Index (APRI) determines the likelihood of hepatic fibrosis and cirrhosis in patients with Hepatitis C. Jan 1, 2016 · The APRI index includes two simple and cheap laboratory tests performed routinely in clinical practice. Currently, a biopsy is the most common method for diagnosing liver fibrosis. 6 % and a specificity of 84. bqmeg iabsty grtf xuir qrekhfr vyhhs sihj tng zhgyz isq